MONTREAL and CHARLOTTE, N.C., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST) (the “Company” or “Milestone”), today announced that the Company granted equity awards, in the form of a total of 113,000 options (the “Options”) to purchase the Company’s common shares, pursuant to the Company’s 2021 Inducement Plan (the “Plan”), previously approved by the Company’s Compensation Committee and the Board of Directors, as a material inducement to employment of three new hires.  The Op ...

About this content About Oliver Haill Oliver has been writing about companies and markets since the early 2000s, cutting his teeth as a financial journalist at Growth Company Investor with a focusing on AIM companies and small caps, before a few years later becoming a section editor and then head of research. He joined Proactive after a couple of years freelancing, where he worked for the Financial Times Group, ITV, Press Association, Reuters sports desk, the London Olympic News Service, Rugby World Cup ...

The Nasdaq Composite (^IXIC 1.24%) has been a great performing index, as it beat the broader S&P 500 (^GSPC 0.55%) in 2024 by rising 28.6% versus the S&P 500's 23.3%. It wouldn't surprise me to see those results again in 2025, but I think a few companies within the Nasdaq Composite can outperform the broader index in 2025.These stocks are Meta Platforms (META 4.23%), Alphabet (GOOG 2.50%) (GOOGL 2.65%), ASML (ASML 7.58%), PayPal (PYPL 2.20%), and MercadoLibre (MELI -1.90%). I think all five of these stocks ...

The CNN Money Fear and Greed index showed some easing in the overall fear level, while the index remained in the “Fear” zone on Monday.U.S. stocks settled mostly higher on Monday, with the S&P 500 and Nasdaq Composite recording back-to-back gains during the session.Chip stocks were among the top gainers of the session after Foxconn disclosed record revenue for the fourth quarter. Nvidia Corp. NVDA shares gained 3.4%, while Micron Technology Inc. MU jumped 10.5% on Monday.Among Monday's notable headlines, Th ...

STATEN ISLAND, N.Y., Jan. 6, 2025 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("we" or "Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, today announced that it has entered into a definitive agreement for the purchase and sale of an aggregate of 2,463,058 shares of its common stock at a purchase price of $1.015 per share in a registered direct offering priced at-the-market under Nasdaq rules. In ...

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite jumping more than 200 points on Monday.The Dow traded up 0.08% to 42,765.84 while the NASDAQ gained 1.05% to 19,828.63. The S&P 500 also rose, gaining, 0.59% to 5,976.38.Check This Out: This Analyst With 85% Accuracy Rate Sees Around 16% Downside In Tesla – Here Are 5 Stock Picks For Last Week From Wall Street’s Most Accurate AnalystsLeading and Lagging SectorsInformation technology shares jumped by 2.1% on Monday.In trading on M ...

Shares of T-Mobile (TMUS -3.98%) fell 4.3% on Monday as of 11:37 a.m. ET, a notable decline even as the Nasdaq Composite (^IXIC 1.46%) was up over 1.8% by that time.T-Mobile was a massive winner in 2024, finishing the year up 40% with dividends included. However, with its shares perhaps reflecting the strength of its business and the full synergies from the 2020 Sprint merger, two Wall Street analysts both downgraded shares today. Wells Fargo and RBC move to the sidelinesToday, sell-side analysts at both We ...

EnglishItalianoEspañolPortuguêsDeutschالعربيةFrançaisImportant DisclaimersThe content provided on the website includes general news and publications, our personal analysis and opinions, and contents provided by third parties, which are intended for educational and research purposes only. It does not constitute, and should not be read as, any recommendation or advice to take any action whatsoever, including to make any investment or buy any product. When making any financial decision, you should perform your ...

NeuroSense in Compliance with all Nasdaq Listing RequirementsCAMBRIDGE, Mass., Jan. 6, 2025 /PRNewswire/ -- NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a late-stage clinical biotechnology company developing novel treatments for severe neurodegenerative diseases, today announced that the Company received formal written notice from The Nasdaq Stock Market LLC ("Nasdaq") that the Company has regained compliance with Nasdaq's stockholders' equity requirement ("Equity Requirement") set forth in ...

Win Prizes and Potentially Elevate Your Options Trading Expertise with Moomoo's Pro-Level Trading Platform Risk-FreeJERSEY CITY, N.J., Jan. 6, 2025 /PRNewswire/ -- Moomoo, the intuitive investment and trading platform that offers $0 commission options trading services [1], will launch an Options Paper Trading Challenge ("the Challenge") in the U.S. This presents an outstanding opportunity for U.S. investors to develop, showcase, and refine their trading strategies within a competitive, risk-free, and simula ...